PRE-CLINICAL STUDIES FOR ADVANCING CIRMTUZUMAB-BASED ANTI-ROR1 THERAPIES IN METASTATIC PROSTATE CANCER

被引：0
|
作者：
Muldong, Michelle
Lee, Sanghee
Mendoza, Theresa
Burner, Danielle
Wu, Christina
Murtadha, Jamillah
Koutouan, Evodie
Pineda, Naomi
Pineda, Gabriel
Lennon, Kathleen
Hao Pham
Willert, Karl
Cacalano, Nicholas
Jamieson, Catriona
Gaasterland, Terry
Kane, Christopher
Kulidjian, Anna
Jamieson, Christina
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD07-04
引用
收藏
页码：E99 / E99
页数：1
相关论文
共 50 条
  • [11] Developing combination therapies for hormone-refractory prostate cancer in a pre-clinical mouse model of the disease
    Abate-Shen, C.
    Kinkade, C. W.
    Castillo-Martin, M.
    Cordon-Cardo, C.
    EJC SUPPLEMENTS, 2008, 6 (12): : 7 - 7
  • [12] The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies
    Newell, DR
    Silvester, J
    McDowell, C
    Burtles, SS
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (06) : 899 - 906
  • [13] Dietary pterostilbene is a novel chemopreventive and therapeutic agent in prostate cancer: Pre-clinical studies
    Levenson, Anait
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [14] Immune-Based Therapies for Traumatic Brain Injury: Insights from Pre-Clinical Studies
    Machado, Caroline Amaral
    Simoes e Silva, Ana Cristina
    de Miranda, Amanda Silva
    e Cordeiro, Thiago Macedo
    Ferreira, Rodrigo Novaes
    de Souza, Leonardo Cruz
    Teixeira, Antonio Lucio
    de Miranda, Aline Silva
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (32) : 5374 - 5402
  • [15] Pre-clinical efficacy of the Wnt pathway inhibitor RXC004 in combination with anti-cancer therapies
    Kelly, James
    Woodcock, Simon
    Bhamra, Inder
    Jones, Cliff
    Armer, Richard
    Robertson, Jane
    Phillips, Caroline
    CANCER RESEARCH, 2022, 82 (12)
  • [16] A Novel, Spontaneously Immortalized, Human Prostate Cancer Cell Line, Bob, Offers a Unique Model for Pre-Clinical Prostate Cancer Studies
    Attard, Gerhardt
    Rizzo, Sian
    Ledaki, Ioanna
    Clark, Jeremy
    Reid, Alison H. M.
    Thompson, Alan
    Khoo, Vincent
    de Bono, Johann S.
    Cooper, Colin S.
    Hudson, David L.
    PROSTATE, 2009, 69 (14): : 1507 - 1520
  • [17] Targeting prostate cancer with NM-404, a radioiodinated phospholipid ether analog: Pre-clinical studies
    Wahl, RL
    Longino, MA
    Pinchuk, AN
    Skinner, S
    Fisher, SJ
    VanDort, M
    RADIOLOGY, 2000, 217 : 219 - 219
  • [18] Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
    Naeimzadeh, Yasaman
    Tajbakhsh, Amir
    Nemati, Mahnaz
    Fallahi, Jafar
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 978
  • [19] Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies
    Marlet, Ida R.
    Olmestig, Joakim N. E.
    Vilsboll, Tina
    Rungby, Jorgen
    Kruuse, Christina
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) : 559 - 569
  • [20] ANTI-CANCER ACTIVITY OF THE SELECTIVE CYP17A1 INHIBITOR, VT-464, IN PRE-CLINICAL MODELS OF CASTRATE RESISTANT PROSTATE CANCER
    Toren, Paul
    Pham, Steven
    Kim, Soojin
    Adomat, Hans
    Zoubeidi, Amina
    Moore, William
    Gleave, Martin
    JOURNAL OF UROLOGY, 2014, 191 (04): : E808 - E808
12345